Anesthesia

Supporting Your Pet's Behavioral Health During the Back-to-Office Transition: Join Trupanion's YouTube Premiere for Expert Guidance

Retrieved on: 
Monday, November 20, 2023
Premiere, Pet, Science, COVID-19, Textbook, Cat, Research, Neuroscience, Parent, Trupanion, Anesthesia, Doctor of Philosophy, Dog, Anxiety, Mental health, Human, Insurance, CLAS, Public, Veterinary medicine, MRCVS, CVA, Neurology, Neuro, Communication

SEATTLE, Nov. 20, 2023 (GLOBE NEWSWIRE) -- As pet parents settle into the school run, work-week routine, Trupanion, the leading insurance provider for cats and dogs, is raising awareness around pet behavioral health, and the potential impact of these transitions on our pets and ourselves.

Key Points: 
  • On December 6, 2023, Trupanion will be hosting a YouTube Premiere, “Understanding & Managing Behavioral Health in Pets”.
  • Throughout the Premiere, panelists will discuss topics pertaining to pet behavioral health and offer expert guidance on how to manage behavioral health issues in our pets.
  • This Premiere comes at a time of rising veterinary visits related to behavioral concerns in pets.
  • In addition to offering guidance to pet owners, the expert panelists will discuss pet behavioral health, including how to recognize behavioral health issues and behavioral, medicinal and therapeutic treatment considerations.

INOTIV ALERT: Bragar Eagel & Squire, P.C. is Investigating Inotiv, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, December 27, 2023
Class Action Lawsuit, Professional Services, Legal, Telephone, Animal Welfare Act, Anesthesia, Seizure, AWA, DOJ, P.C, Face

Our investigation concerns whether the board of directors of Inotiv have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Inotiv have breached their fiduciary duties to the company.
  • On May 20, 2022, Inotiv announced that on May 18 federal and state law enforcement conducted a search and seizure warrant on the Cumberland facility.
  • The company also announced the DOJ sued Envigo for violations of the Animal Welfare Act (“AWA”).
  • Then, on May 21, 2022, the court in the DOJ’s case ordered a halt to violations of the AWA at Cumberland.

Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications

Retrieved on: 
Friday, November 10, 2023
Pain, Foot, Safety, Food, Anesthesia, Achilles tendon, Bupivacaine, Ankle, Patient, FDA, Pharmacokinetics, Hydrogen chloride, Knee, Shanda, Pharmaceutical industry

TAMPA, Fla., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) to expand the EXPAREL® (bupivacaine liposome injectable suspension) label to include administration in adults as an adductor canal block and a sciatic nerve block in the popliteal fossa.

Key Points: 
  • An adductor canal block is used for anesthesia and analgesia for surgery of the knee, medial lower leg, and ankle surgeries.
  • A sciatic nerve block in the popliteal fossa is used for anesthesia and analgesia for foot, ankle, achilles tendon, and other lower leg surgeries.
  • One study evaluated EXPAREL as a single-dose adductor canal block and the second study evaluated EXPAREL as a single-dose sciatic nerve block in the popliteal fossa.
  • EXPAREL as a sciatic nerve block in the popliteal fossa also achieved statistical significance for the percentage of opioid-free subjects (P

New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation

Retrieved on: 
Monday, December 11, 2023
Biotechnology, Surgery, Health, Pharmaceutical, Health Technology, Odds ratio, Samsung Medical Center, De novo, Blood, OLV, Sungkyunkwan University, Hypoxemia, Risk, MASI, Patient, Multimedia, Journal, FDA, Hyperoxia, Oxygen, Blood gas tension, Perioperative, Ori, Oxygen saturation (medicine), Receiver operating characteristic, Medical device, Medical imaging, Anesthesia, ROC

ORi is trended continuously with SpO2 as a unit-less index between 0.00 and 1.00 to extend the visibility of the patient oxygenation beyond SpO2 under supplemental oxygen.

Key Points: 
  • ORi is trended continuously with SpO2 as a unit-less index between 0.00 and 1.00 to extend the visibility of the patient oxygenation beyond SpO2 under supplemental oxygen.
  • During anesthesia, ORi was monitored using Masimo RD rainbow SET® Pulse CO-Oximetry sensors, and blood gas analysis was performed 15 minutes after OLV was initiated.
  • Of the 11 potential predictors for PaO2
  • The researchers concluded, “ORi values during one-lung ventilation were significantly correlated with PaO2 measured simultaneously.

CMS Grants Transitional Pass-Through (TPT) Payment for Ambu’s aScope 5 Broncho HD Single-Use Bronchoscope

Retrieved on: 
Wednesday, December 6, 2023
Medical Supplies, Health, Medical Devices, Hospitals, Surgery, Practice Management, Health Insurance, Safety, Anesthesia, TPT, Patient, Multimedia, Airway management, CMS, Lung cancer, Diagnosis, Medicare, Reactive airway disease, Market access, Physician, Ambu, Inc., Medical device

Ambu Inc. announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has granted the company’s aScope 5 Broncho HD a transitional pass-through (TPT) payment.

Key Points: 
  • Ambu Inc. announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has granted the company’s aScope 5 Broncho HD a transitional pass-through (TPT) payment.
  • View the full release here: https://www.businesswire.com/news/home/20231206904736/en/
    The U.S. Centers for Medicare & Medicaid Services (CMS) has granted Ambu’s aScope 5 Broncho HD a transitional pass-through (TPT) payment.
  • The aScope 5 Broncho HD is a best-in-class single-use bronchoscopy system with high-performance functionality and imaging, combined with single-use’s distinct productivity and safety advantages.
  • TPT was granted to the aScope 5 Broncho HD series because it fit CMS criteria, which included demonstrating a substantial clinical improvement over existing single-use and reusable bronchoscopy technology.

Children’s Hospital Los Angeles Recognized as National Surgical Quality Partner by American College of Surgeons

Retrieved on: 
Tuesday, November 21, 2023
Nursing, Managed Care, Teens, Surgery, Health, Children, Hospitals, Consumer, Digestive system surgery, Children's Hospital Los Angeles, Senior, Anesthesia, Trauma, Cardiology, ACS, SQP, Trauma Center, Patient, Multimedia, FAAP, Division, American College, FACS, Master of Science, News, MBA, MD, Nursing care plan, CHLA, Pediatric surgery, American College of Surgeons, Dentistry, Management, Orthopedic surgery, Surgeon, Urology, Neonatology, Nephrology

Children’s Hospital Los Angeles (CHLA) has been recognized as a National Surgical Quality Partner (SQP) by the American College of Surgeons (ACS) for its long-standing dedication to the highest standards in surgical patient care.

Key Points: 
  • Children’s Hospital Los Angeles (CHLA) has been recognized as a National Surgical Quality Partner (SQP) by the American College of Surgeons (ACS) for its long-standing dedication to the highest standards in surgical patient care.
  • View the full release here: https://www.businesswire.com/news/home/20231121829446/en/
    Children’s Hospital Los Angeles leadership and team members gather in front of the newly installed American College of Surgeons Surgical Quality Partner plaque.
  • The SQP designation lets patients know that Children’s Hospital Los Angeles is dedicated to relentless self-improvement and has been verified through a detailed and rigorous review from ACS.
  • “We are immensely proud to be named an ACS Surgical Quality Partner,” said James Stein, MD, MSc, FACS, FAAP, Senior Vice President and Chief Medical Officer at Children’s Hospital Los Angeles.

U.S. Anesthesia Partners Files Motion to Dismiss FTC’s Misguided Civil Complaint

Retrieved on: 
Tuesday, November 21, 2023
Professional Services, Medical Supplies, Health, Surgery, Legal, Other Health, General Health, Complaint, USAP, Protocol, Patient, Anesthesia, Federal Trade Commission, District court, FTC, Anesthesiology

U.S. Anesthesia Partners (“USAP”), a leading provider of high-quality anesthesia care, today filed a motion to dismiss the Federal Trade Commission’s (FTC) civil complaint alleging that certain USAP business practices violate U.S. competition laws.

Key Points: 
  • U.S. Anesthesia Partners (“USAP”), a leading provider of high-quality anesthesia care, today filed a motion to dismiss the Federal Trade Commission’s (FTC) civil complaint alleging that certain USAP business practices violate U.S. competition laws.
  • USAP filed a motion to dismiss the complaint because, among other things, the FTC has inaccurately represented the anesthesia market in Texas and has failed to properly allege that USAP has monopoly power by charging more than a competitive price.
  • It is an attack on our independent, physician-owned and physician-led medical practice rather than a valid complaint that has credible allegations of anticompetitive harm.
  • Dr. Derek Schoppa, another practicing USAP physician in Texas and a USAP Board member, added: “The FTC’s allegations are misguided.

Mindray Donates to the University of Washington School of Medicine to Kickstart Advanced Emergency Medicine Ultrasonography Fellowship Program

Retrieved on: 
Thursday, December 14, 2023
Anesthesia, Patient, Emergency medicine, University, Corporate communication, Physician, Knowledge, Health, Education, Medical imaging, Mindray, Medicine

MAHWAH, N.J., Dec. 14, 2023 /PRNewswire-PRWeb/ -- Mindray, a global developer of healthcare technologies and solutions for ultrasound, patient monitoring, and anesthesia, announced today its significant financial gift to the University of Washington School of Medicine, which will help initiate the groundbreaking Advanced Emergency Medicine Ultrasonography Fellowship Program. This gift underscores Mindray's unwavering commitment to advancing medical education and fostering the next generation of healthcare professionals.

Key Points: 
  • MAHWAH, N.J., Dec. 14, 2023 /PRNewswire-PRWeb/ -- Mindray, a global developer of healthcare technologies and solutions for ultrasound, patient monitoring, and anesthesia, announced today its significant financial gift to the University of Washington School of Medicine, which will help initiate the groundbreaking Advanced Emergency Medicine Ultrasonography Fellowship Program.
  • The UW School of Medicine's Advanced Emergency Medicine Ultrasonography Fellowship Program's goal is to be the most unique and innovative ultrasound fellowship program in the country.
  • The program aims to equip physicians with advanced skills and knowledge in point of care ultrasound , a critical tool in modern emergency care.
  • "We are appreciative of this gift from Mindray," said Dr. Ross Kessler, program director for the fellowship program at UW Medicine.

Dental Care Alliance Welcomes New Chief Financial Officer

Retrieved on: 
Thursday, December 14, 2023
DCA, Russell Allen, Dental care, Senior, CFO, Dentist, DSO, Accounting, Patient, MEDNAX, MBA, Florida International University, Growth, Dentistry, Management, Anesthesia

SARASOTA, Fla., Dec. 14, 2023 /PRNewswire-PRWeb/ -- Dental Care Alliance (DCA), one of the nation's leading Dental Support Organizations, is pleased to announce that Victoria Garcia was named as the organization's new Chief Financial Officer in June 2023.

Key Points: 
  • Dental Care Alliance (DCA), one of the nation's leading Dental Support Organizations, is pleased to announce that Victoria Garcia was named as the organization's new Chief Financial Officer in June 2023.
  • SARASOTA, Fla., Dec. 14, 2023 /PRNewswire-PRWeb/ -- Dental Care Alliance (DCA), one of the nation's leading Dental Support Organizations, is pleased to announce that Victoria Garcia was named as the organization's new Chief Financial Officer in June 2023.
  • She is a dynamic leader and brings extensive finance and strategy experience to the executive team," shared Jason Heffelfinger, DCA's Chief Executive Officer.
  • Dental Care Alliance's mission is to advance the practice of dentistry by partnering with and supporting dental professionals to create a lifetime of healthy smiles.

Radiopharmaceuticals market size to grow by USD 4.37 billion from 2021 to 2026 | Actinium Pharmaceuticals Inc., Bayer AG, Bracco Spa, BWX Technologies Inc. and more among the key companies in the market - Technavio

Retrieved on: 
Tuesday, December 12, 2023
Radiation, Anesthesia, Incidence, ROW, Investment, DSM-IV codes, Radiopharmaceutical, Adsorption, GE HealthCare, USD, Diagnosis, Geography, Partnership, Growth, Isotopes of molybdenum, PET, Cancer, SPECT, Medical imaging, Pharmaceutical industry

Based on geography, the global radiopharmaceuticals market is segmented into North America, Europe, Asia, and Rest of World (ROW).

Key Points: 
  • Based on geography, the global radiopharmaceuticals market is segmented into North America, Europe, Asia, and Rest of World (ROW).
  • The report provides actionable insights and estimates the contribution of all regions to the growth of the global radiopharmaceuticals market.
  • Key trends - Partnerships for the development of radiopharmaceuticals are supporting the radiopharmaceuticals market growth.
  • Major challenges – Preparation and dispensing problems associated with radiopharmaceuticals are challenging the radiopharmaceuticals market growth.